What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Neuroscience
- Psychiatry
Fabrizio Benedetti mainly investigates Placebo, Nocebo, Analgesic, Nocebo Effect and Anesthesia.
The study incorporates disciplines such as Internal medicine, Clinical trial, Disease, Psychotherapist and Endogenous opioid in addition to Placebo.
His Nocebo research includes themes of Psychiatry, Cognition, Anxiety and Audiology.
His Analgesic study incorporates themes from Endocrinology and Opioid.
His research investigates the connection between Nocebo Effect and topics such as Hyperalgesia that intersect with issues in Cortisol secretion and Hydrocortisone.
His studies examine the connections between Anesthesia and genetics, as well as such issues in Buprenorphine, with regards to Basal, Randomized controlled trial, Saline, Tramadol and Ketorolac.
His most cited work include:
- A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought (814 citations)
- Biological, clinical, and ethical advances of placebo effects (794 citations)
- Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems (689 citations)
What are the main themes of his work throughout his whole career to date?
Fabrizio Benedetti spends much of his time researching Placebo, Nocebo, Anesthesia, Clinical trial and Nocebo Effect.
The various areas that Fabrizio Benedetti examines in his Placebo study include Psychotherapist, Analgesic, Physical therapy and Endogenous opioid.
His studies deal with areas such as Opioid antagonist and Pharmacology as well as Endogenous opioid.
His Nocebo course of study focuses on Anxiety and Cognition.
Fabrizio Benedetti interconnects Placebo analgesia, Randomized controlled trial, Buprenorphine, Opioid and Heart rate in the investigation of issues within Anesthesia.
His studies in Clinical trial integrate themes in fields like Alternative medicine, Physical medicine and rehabilitation, Clinical psychology and Intensive care medicine.
He most often published in these fields:
- Placebo (67.30%)
- Nocebo (30.33%)
- Anesthesia (25.12%)
What were the highlights of his more recent work (between 2017-2021)?
- Placebo (67.30%)
- Nocebo (30.33%)
- Nocebo Effect (19.43%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Placebo, Nocebo, Nocebo Effect, Clinical trial and Anesthesia.
The Placebo study combines topics in areas such as Psychological intervention, Internal medicine, Randomized controlled trial, Psychotherapist and Physical therapy.
Fabrizio Benedetti works mostly in the field of Nocebo, limiting it down to concerns involving Hyperalgesia and, occasionally, Headache pain.
His Nocebo Effect study integrates concerns from other disciplines, such as Psychosocial, Psychiatry, Expert consensus and Dorsolateral prefrontal cortex.
His Clinical trial research is multidisciplinary, relying on both Adverse effect, Placebo response, Disease and Intensive care medicine.
His Anesthesia research is multidisciplinary, incorporating elements of Placebo analgesia, Clinical endpoint, Atopic dermatitis and Heart rate.
Between 2017 and 2021, his most popular works were:
- Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus. (121 citations)
- Consensus statement on placebo effects in sports and exercise: The need for conceptual clarity, methodological rigour, and the elucidation of neurobiological mechanisms. (31 citations)
- What Is the Role of the Placebo Effect for Pain Relief in Neurorehabilitation?: Clinical Implications From the Italian Consensus Conference on Pain in Neurorehabilitation (29 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Neuroscience
- Psychiatry
The scientist’s investigation covers issues in Placebo, Nocebo, Clinical trial, Psychotherapist and Nocebo Effect.
The concepts of his Placebo study are interwoven with issues in Anesthesia, Neuropathic pain, Response rate, Internal medicine and Physical therapy.
His Physical therapy research incorporates themes from Analgesic and Postherpetic neuralgia.
His Nocebo research includes elements of Adalimumab, Biosimilar, Adverse effect, Perfusion scanning and Oxygenation.
His Clinical trial study combines topics from a wide range of disciplines, such as Drug development, Infliximab and Intensive care medicine.
Fabrizio Benedetti combines subjects such as Headache pain, Expert consensus and Hyperalgesia with his study of Psychotherapist.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
